Hypothyroidism



Bristol-Myers Squibb pioneered the use of immune checkpoint inhibitors for the adjuvant treatment of melanoma, beginning with Yervoy. Five-year overall...


Immunotherapy in multiple myeloma is emerging as an effective modality in therapy of multiple myeloma with the approval of several...


The Food and Drug Administration ( FDA ) has approved Keytruda ( Pembrolizumab ), the anti-PD-1 ( programmed death receptor-1...


Merck, known as MSD outside the United States and Canada, has announced new study findings investigating the use of Keytruda...


Findings investigating the use of Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, in multiple, difficult-to-treat cancers, including advanced small cell...


Keytruda ( Pembrolizumab ) is indicated in the United States at a dose of 2 mg/kg administered as an intravenous infusion over...


The aim of a study was to identify risk factors for the development of statin-associated diabetes mellitus ( DM ). The...


Keytruda ( Pembrolizumab ) is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and...


New data from KEYNOTE-001, a phase 1b study evaluating Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, in naïve and previously-treated...


Results from the pivotal KEYNOTE-010 study, the first study of its kind to evaluate the potential of an immunotherapy compared...


Immunotherapies stimulate the immune system with the goal of eradicating tumors, and some side effects are likely related to this...


In 2004, the U.S. Preventive Services Task Force found insufficient evidence to recommend thyroid screening. The purpose of a research...


Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, has achieved an overall response rate of 66%, as assessed by International Harmonization...


The European Commission ( EC ) has granted marketing authorization for Plegridy ( Peginterferon beta-1a ) as a treatment for...


Thyroid hormones have a significant impact on heart function, mediated by genomic and non-genomic effects. Consequently, thyroid hormone deficiencies, as...


Small cross-sectional studies have suggested that Metformin, a first-line oral hypoglycemic agent, may lower thyroid-stimulating hormone ( TSH ) levels....


The U.S. Food and Drug Administration ( FDA ) has approved Keytruda ( Pembrolizumab ) at a dose of 2...


New data from the phase 1b study ( KEYNOTE-001 ) evaluating Pembrolizumab ( MK-3475 ), an investigational anti-PD-1 antibody, as...